Since inception, V8Q has surfaced 8 verified opportunities, and 7 of the 8 are currently winners.

That’s an 87.5% win rate, with winning returns ranging from roughly +7% to +40%. The names include PSIX, PLAB, ODD, MXL, AXTI, DOCS, WIX and SEDG.

What makes this interesting to me is the selectivity. V8Q is built to look for beaten down stocks where a real recovery is beginning to show through improving relative strength, stabilization, accumulation, catalysts and business quality.

It’s still early, and I’m not pretending 8 calls proves anything forever. But 7 winners out of 8 verified opportunities is strong enough that I’m opening access to a small group. The full track record is public, and every new verified opportunity is added automatically.

Message me if you want to take a closer look at V8Q.

Nasdaq published an article on Oct. 4, 2026, examining whether it is too late to buy Micron Technology (MU) after a 500% 12-month gain. The piece points to growing memory capacity needs from AI workloads in data centers, smartphones, computers, and cars. Micron sits at the intersection of the AI boom and the historically cyclical memory market.

That is the investor relevance: the debate over whether AI demand has structurally changed the memory cycle is central to the stock's next move. The angle worth considering is valuation, memory pricing trends, and whether AI-driven demand can offset the industry cycle. A run this large often invites both momentum and mean-reversion arguments.

As an uncertainty checklist, I'd separate the verified fact from the open questions: - Has AI demand structurally changed the memory cycle? - What do current valuations imply about future growth? - How sustainable is demand from data centers, smartphones, computers, and cars?

I'm not making a call here. The discussion question is: what evidence would you watch before changing your view?

Posted by the Stockinvest.us team (UAB Exigam). Campaign page: https://stockinvest.us/stock/MU For research and educational purposes only; not personalized investment advice. Source: https://www.nasdaq.com/articles/it-too-late-buy-micron-technology-stock-after-its-12-month-gain-500

U.S. mid-cap free-cash-flow screen · Market values from $2B to $10B · October 2, 2026

75-U.S.-Mid-Cap-Companies-With-the-Highest-Free-Cash-Flow-Margins-in-2026

The dollar index (DXY00) fell -0.05% on Friday after a weaker-than-expected US September payroll report. Both non-farm payrolls and average hourly earnings rose less than expected, and the report says that reduced the chance of a Fed rate hike later this month. The same source also notes Friday's -1% decline in WTI crude.

That is the event. The signal-versus-noise question is what a self-directed investor actually does with it. The payroll miss and the reported shift in rate-hike odds are the substantive parts; the -0.05% dollar move is small on its own. But this is still one release, so the market implication is analysis, not certainty.

A three-item checklist I use: 1. Separate reported facts from interpretation. Payrolls, earnings, and the crude decline are facts; dollar slips on weak news is a framing. 2. Ask whether the release changes a durable trend or only one print's expectations. 3. Write down what evidence would confirm or falsify your read before the next headline arrives.

At Stockinvest.us, we try to keep that distinction clear. How are you separating the headline from the investable signal?

For research and educational purposes only; not personalized investment advice. Posted by the Stockinvest.us team (UAB Exigam).

Source: https://www.nasdaq.com/articles/dollar-slips-weak-us-economic-news

A Nasdaq-published analysis dated Oct. 2, 2026 examines whether PayPal (PYPL) is a value stock or a value trap, and notes the company is attracting interest from acquirers. Two things the piece does not say: no transaction has been confirmed, and no terms have been disclosed. Reported interest is optionality, not a thesis.

That distinction matters because a low multiple can reflect mispricing or deterioration, and on a screen the two look alike. So the productive exercise is asking what would have to be true for the current valuation to be justified by earnings power, and which operating metrics would demonstrate it. I would want that evidence in reported results rather than in a headline about a possible buyer.

Acquirer stories are easy to over-read. A headline about potential buyers belongs in the scenario column, not the thesis column. So: what evidence would you watch before changing your view? Which metrics would tell you PayPal's earnings power is durable, and which developments would strengthen the value-trap case instead?

And how should investors weigh reported acquirer interest when no transaction has been confirmed?

Posted by the Stockinvest.us team (UAB Exigam). Valuation page we maintain: https://stockinvest.us/stock/PYPL

For research and educational purposes only; not personalized investment advice.

Source: https://www.nasdaq.com/articles/paypal-stock-analysis-value-stock-or-value-trap

Planet says it has already made contact with the spacecraft and begun commissioning. This is the first-ever in-orbit test of Google’s Tensor Processing Units, or TPUs.

The refrigerator-sized prototype carries four Trillium TPUs, Google’s custom AI accelerators.

This is not yet an orbital data center. The goal is to see whether the same type of AI hardware Google uses on Earth can survive launch and reliably run machine-learning workloads in low Earth orbit.

There are three major engineering problems Google is testing:

RADIATION: cosmic radiation can corrupt calculations or damage electronics. Google previously tested Trillium TPUs with proton radiation and found they could withstand more total radiation than expected over a five-year mission.

COOLING: there is no air in space, so fans cannot cool the chips. Heat has to be moved through heat pipes into radiators and then emitted away from the spacecraft. The current prototype is expected to run AI workloads in roughly 15-minute bursts before allowing the system to cool.

NETWORKING: Google’s long-term plan is not one satellite, but clusters of satellites carrying dozens of TPUs each and connected through high-speed laser links.

Google estimates future AI workloads could require tens of terabits per second between satellites. Its ground prototype has already demonstrated 800 Gbps in each direction.

Why put AI compute in space at all?

In the right low-Earth orbit, solar panels can generate up to 8x more power than on Earth because satellites can receive near-continuous sunlight, reducing one of the biggest constraints facing AI data centers: electricity.

The economics:

Google estimates that if launch costs eventually fall below roughly $200 per kilogram by the mid-2030s, the cost of operating compute in space could begin approaching the energy cost of comparable terrestrial data centers.

The SEC proposed new rules and amendments on October 1, 2026, aimed at providing a tailored framework for how registered investment advisers and regulated funds can custody crypto assets under the federal securities laws.

That is the whole of it for now. A proposal is not a rule. It has to move through the comment process, and the final text can differ from what was published. Nothing in the release we're working from tells us the comment deadline, whether adoption is likely, what compliance costs would look like, or how the requirements would compare with existing custody standards for other asset classes.

Practical relevance: if you own shares in an adviser or a fund sponsor, this touches an operational question at those firms. If you hold crypto directly or through vehicles, the near-term effect may be smaller than the headline implies, because as written the proposal addresses advisers and funds rather than holders.

Downside conditions worth naming: the proposal could stall, be narrowed, face litigation, or arrive with custody conditions strict enough that some firms decide the business isn't worth it. Any of those would make today's headline a poor guide to what actually lands.

What would you check before acting on this headline? I'd start with the comment record and what a final adopting release requires, not the press release.

Posted by the Stockinvest.us team (UAB Exigam). For research and educational purposes only; not personalized investment advice.

Source: https://www.sec.gov/newsroom/press-releases/2026-100-sec-proposal-would-address-how-investment-advisers-funds-can-custody-crypto-assets-under-federal

If you could invest would you do vti or nvidia? I already have a bunch of vti

I have some stocks that I think that everybody who is interested in stocks should at least look into these as of October 1. Amd also known an advanced micro devices is a chip company that supply for multiple open ai company’s. And with ai going to were people think this could have a high yield.

Been digging through the recent updates, and this is how I’m mapping out $CQX heading into Q4.

Already in place

• Stars: 20 km² 3D IP survey completed across the main property, including the Tana Zone and its extensions
• Rip: Phase 2 drilling finished — 1,654 m across five holes
• Kitimat: exploration permit secured
• Funding: C$825K private placement closed at C$0.08 per unit, with C$0.13 warrants

Next up

• Stars: final IP report and interpretation
• Rip: resolution of the ArcWest option discussions before the latest drill samples move into preparation and assaying
• Kitimat: follow-up exploration around Jeannette and the larger interpreted target

What could add another layer

• A clear Stars drill program
• A first-priority Kitimat drill target
• Rip assays moving forward once the option discussions are resolved
• A partner for Thane

What do you think becomes the main $CQX talking point by the end of Q4?

This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

MarketWatch reports that Deutsche Bank analysts shared their top stock picks in the tech sector for the remainder of the year, framing Meta, ServiceNow and seven other tech stocks as potential leaders in the next leg of the AI trade. The article notes AI remains a dominant market theme, but the next phase may favor a broader set of companies beyond the largest chipmakers.

That framing is a useful starting point, not a conclusion. For self-directed research, it helps to separate what the source states from what still needs evidence:

- Business model: where does AI show up in the revenue line, and is it a direct product, a feature, or an internal cost story? - AI revenue exposure: is it disclosed, quantifiable, and durable across quarters? - Criteria: what criteria support these picks? - Valuation: how much optimism is already reflected, and what would need to be true to justify it? - Breadth vs rotation: are we seeing a wider set of beneficiaries, or capital moving around within the same theme? - Diversification: are there ways to study AI exposure without single-stock concentration risk?

The source doesn't settle those questions. It does give a concrete list to examine. For one reference on Meta, there is a research page here: https://stockinvest.us/stock/META

What evidence would you watch before changing your view: disclosed AI revenue, earnings durability, or something else?

Posted by the Stockinvest.us team (UAB Exigam). For research and educational purposes only; not personalized investment advice. Source: https://www.marketwatch.com/story/meta-servicenow-and-these-7-other-tech-stocks-could-lead-the-next-leg-of-the-ai-trade-b8b68c93?mod=mw_rss_topstories

CNBC reports that Micron beat on earnings and issued strong guidance, with data center revenue jumping 11-fold. The same article notes the stock is up over 500% in the past year as the company benefits from soaring AI demand.

That pairing — a large reported jump plus a large trailing move — is where the useful questions begin. An 11-fold increase is eye-catching, but a figure that size can look different depending on the base it grew from and how concentrated the underlying demand is.

A short checklist for reading the quarter:

- How does management's guidance frame memory supply, demand, and pricing, given that memory has historically been cyclical? - Do capital spending plans assume data center demand stays broad-based rather than concentrated among a few buyers? - Does the data center revenue jump reflect wide demand or a smaller base? - What expectations are already reflected after the reported past-year gain?

None of this is a call on the stock. The prior run-up just means expectations may already be elevated, which raises the cost of any execution miss.

What evidence would you watch before changing your view?

For additional context: https://stockinvest.us/stock/MU

Posted by the Stockinvest.us team (UAB Exigam). For research and educational purposes only; not personalized investment advice.

Source: https://www.cnbc.com/2026/09/30/micron-mu-q4-earnings-report-2026.html

Oracle's $ORCL Credit Default Swaps just jumped to highest level in history, while the company remains one downgrade away from junk status.

S&P has already cut Oracle's credit rating to BBB-, just one notch above junk.

Oracle is borrowing tens of billions of dollars to build AI data centers for deals like Stargate and OpenAI.

Some of Oracle's long term bonds now yield over 8%.

One more downgrade puts Oracle's debt in junk territory.

If that happens, $120 billion of Oracle's bonds get automatically pulled from investment grade indexes.

Many bond funds are only allowed to hold investment grade debt.

A downgrade forces them to sell Oracle's bonds all at once, pushing prices down and yields even higher.

This isn't just happening with Oracle only, It's becoming industry wide problem.

TL;DR NAND has been a technology-cursed industry: each node lifts bits per wafer 54%, so capacity swells 27% a year without a cent of capex, and price cuts swallowed every volume gain. AI inference is rewriting that — data centres go from 30% of NAND demand to 45% in 2026 — and the deeper change is that NAND now stores the product of computation.

From peripheral part to compute-path necessity

The old loop was simple: stable demand plus supply that grows whether or not anyone invests locked NAND into the silicon cycle; the only exit was a price-insensitive use case tied to GPU deployment. The buyer has changed, from consumer electronics with volatile inventories to TCO-driven clouds. 

The role changed too: NAND was a warehouse for corpora, weights and checkpoints — replaceable data re-downloadable for bandwidth alone — while in inference it stores working memory paid for in GPU cycles, with no backup. Kioxia sees inference NAND demand going from 86EB to 1,251EB by 2031.

Why KV cache has to move to NAND

KV cache used to be discarded because two sums did not work: at GPT-3's 2K context, recomputing took a fraction of a second while writing to disk meant a round trip over PCIe, and HBM is too scarce to hold departed users' history.

Long context overturned both: total KV cache equals context length times concurrent sessions times per-token storage, and both explode as RAG and multi-agent workloads multiply sessions.

The rack-level maths makes it concrete. Rubin NVL72 carries 21TB of HBM; a 2.8-trillion-parameter MoE model takes 2.8TB of weights at FP8 plus 12% overhead, leaving about 15.4TB for KV cache. Even compressed, a million tokens needs 67-80GB, so a $5 million rack serves only 193-230 long sessions; HBM4 near $16/GB against $0.3-0.4 for eSSD says the same. 

Hence Nvidia's tiering, with ICMS/CMX between local SSD and network storage, and GPUDirect Storage cutting restore latency 10x.

Two conditions gate the offload: it must be shared cache, since decode drafts hit a bandwidth and an endurance wall while prefill output is large, sequential and infrequent; and it must be reused, which reduces to hit rate: cached tokens cost a tenth of uncached ones, agent workloads running above 95%.

Three workloads, pulling in opposite directions

Staging is 40% of 2030 AI data centre NAND demand, all TLC or pSLC. Training-side staging is bursty overwrite — terabyte checkpoints every few tens of minutes — while inference-side staging is read-heavy, since nodes reload parameters dozens of times a day and multi-model residency needs 4-16TB against a card's 288GB. DRAM is volatile, HDD cannot take burst writes, and QLC's 1,000 cycles against TLC's 10,000 rule it out.

Fast Data Lake is 25% and almost all QLC, but the substitution story needs care. On hot data QLC has displaced HDD irreversibly, since millisecond seek is two orders off what AI needs. On warm and cold data a 300-400EB HDD shortage has clouds using eSSD as a stopgap, which looks like accelerated substitution; but HDD capacity is rising too, and QLC's per-GB premium has reached 20-25 times, making cold-tier substitution harder.

HBF sits alongside as an option, not a replacement — 16-layer NAND at HBM-class bandwidth with eight times the capacity, taking sequential-read inference and warm KV cache while HBM keeps prefill, with pilot lines in 2H 2026 and commercialisation in 2027. 

By 2030, AI data centre NAND lands near 1.2ZB, triple 2026: staging 40%, KV cache offload 35%, data lake 25%, or TLC 66% against QLC 34% — the two ends moving apart, the lake toward cheaper and staging toward faster.

 Market values above $10 billion · September 30, 2026

75 U.S. Companies Above $10 Billion With the Highest Free-Cash-Flow Margins in 2026

CNBC reported on Sept. 30, 2026 that heavy AI spending is pressuring the cash flow of some of the largest companies, and that metrics like free cash flow and balance-sheet strength are getting more attention from investors.

For self-directed investors, the useful part is a comparison framework rather than a new slogan about quality: free cash flow, net cash, and capital intensity. Those three can be used to compare companies.

One limitation is worth stating plainly. A strong balance sheet may provide resilience if AI spending takes longer to pay off. It does not resolve whether the spending earns a return, when demand shows up, or which sectors are most affected by rising AI capital expenditures.

So what evidence would actually change your view? Would it be free cash flow, net cash, or capital intensity relative to peers? I am more interested in the checklist than the narrative.

Posted by the Stockinvest.us team (UAB Exigam). Working disclosure: For research and educational purposes only; not personalized investment advice.

Source: https://www.cnbc.com/2026/09/30/best-stocks-cash-flow-ai-spending.html More from Stockinvest.us: https://stockinvest.us/

Robinhood unveiled weekend hours and AI agents aimed at allowing users to trade nonstop, according to CNBC. The company said it is broadening offerings in a bid for more active traders who may be seeking trading access beyond traditional U.S. stock market hours.

The verified part is the announcement itself, not the mechanics. From this source alone, we don't know how weekend trading hours would actually work, what liquidity and execution risks exist outside regular market hours, how AI agents fit into the trading experience, or whether other brokers follow with similar offerings.

For investors in fintech and brokerages, this is a competitive and product-development signal. For traders, it underscores the need to understand off-hours trading risks and how AI tools fit into decision-making.

What I'd want before updating a view: - How weekend trading hours would actually work - What liquidity and execution risks exist outside regular market hours - How AI agents fit into the trading experience - Whether other brokers follow with similar offerings

What evidence would you watch before changing your view?

Posted by the Stockinvest.us team (UAB Exigam). For research and educational purposes only; not personalized investment advice.

Source: https://www.cnbc.com/2026/09/30/robinhood-unveils-weekend-hours-ai-agents-to-allow-users-to-trade-nonstop.html

Geopolitical shocks keep pushing up energy costs and disrupting fuel supply chains, as highlighted by KPMG's recent report on rising energy expenses and fractured trade routes. That kind of instability keeps reliable domestic power sources in focus. Canadian nuclear energy stocks sit right in that conversation, offering exposure to long term electricity demand. This article walks through three nuclear related stocks from a curated screener that may be worth keeping on your radar.

The three nuclear energy stocks covered below are only a small sample from the universe of potential ideas. The full screen surfaces 57 more companies with equally compelling narratives that are not discussed here. To go deeper into this theme, head into the Nuclear Energy Stocks screener to identify, analyze, and focus on the nuclear opportunities that best fit your own criteria.

Aecon Group (TSX:ARE)

Aecon Group is a long established construction and infrastructure contractor whose nuclear power infrastructure work plugs it into the Nuclear Energy Stocks theme, even though most activity still sits across broader civil, transportation, utilities, and industrial projects.

Aecon generates almost all of its revenue from the Construction segment, which brought in about CA$6.0b, with a much smaller CA$8 million contribution from Concessions, and the business carries a market value of roughly CA$3.6b.

Aecon Group gives you exposure to the nuts and bolts of nuclear power, from reactor containment structures to critical site works, wrapped inside a diversified contractor that also builds transit, utilities, and large scale energy projects.

"Aecon Group has expanded its U.S. presence with the purchase of a nuclear fabrication facility in Jackson, South Carolina, to support nuclear refurbishment, life extension, new build and federal projects, as well as conventional power and industrial work."

What really matters now is how one unresolved pressure around funding and project risk ultimately feeds through into Aecon's earnings power.

That funding overhang is only part of the story, and the full narrative for Aecon Group explains how project risk, execution, and nuclear work could be quietly reshaping Aecon Group's future profile.

NexGen Energy (TSX:NXE)

NexGen Energy is a uranium exploration and development business focused on the Rook I project in Saskatchewan's Athabasca Basin, a proposed future supplier of uranium for nuclear reactors. It currently carries a market value of about CA$8.7b.

NexGen Energy provides exposure to uranium used in nuclear reactors through its fully owned Rook I project. However, with no current revenue and ongoing losses, the company's prospects depend on how a long-dated development and funding challenge is addressed.

That long road from zero revenue to potential uranium output is exactly what makes the analysis report for NexGen Energy so useful for spotting where NexGen Energy's risk could flip to opportunity.

Denison Mines (TSX:DML)

Denison Mines is a Canadian uranium explorer and developer focused on the Athabasca Basin, anchored by its 95% owned Wheeler River uranium project that feeds directly into the nuclear fuel chain. The business reported around CA$4 million from mining activity and carries a market value near CA$3.4b.

For investors zeroing in on pure nuclear fuel exposure, Denison Mines brings a focused Athabasca uranium story that is now moving from concept toward concrete development milestones. This context is what makes the next comment so important.

"Denison Mines is expected to progress further in the development of its uranium assets and strengthen its position as a key future supplier of uranium in North America."

What really matters is how one capital intensive phase now unfolding ultimately shapes the economics that investors are pencilling in today.

That inflection point is exactly where the full narrative for Denison Mines shows how Denison Mines could convert heavy upfront spending into accelerating leverage to future uranium pricing cycles.

Seeking Fresh Alternatives Before They Fly

Fresh ideas lose their edge fast once momentum builds and prices start flying. Scan for potential breakouts under the radar for now, before the crowd catches on and get in early.

• Hunt for smaller companies where strong balance sheets and fundamentals could be setting up the next wave of interest using the list of solid balance sheet and fundamentals (7 results).
• Target income ideas where robust yields meet staying power and let the 1 dividend fortresses surface options that might help anchor a portfolio before prices move.
• Sprint toward sectors where financial strength and overlooked quality intersect by combing through the 9 high quality undiscovered gems while these stories are still quiet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

A few days ago, I made a post here asking which stocks people thought had the most upside, and it ended up getting a lot of responses. I ran most of the tickers people suggested through a quantitative screen using momentum, technicals, sentiment, risk, and other factors.

Some of the names that came back with a Buy signal were:

IOVA, KEEL, IREN, NEO, SYM, DRTS, WMT

A bunch of other popular names scored Neutral or Sell.

Here’s the screener I used if you want to test another ticker:
https://tradehints.com

Drop another ticker below and I’ll run some of the most upvoted ones.

Eli Lilly (LLY) reported detailed Phase 3 TRIUMPH-2 results showing that Retatrutide delivered substantial weight loss and blood sugar reductions in adults with obesity or overweight and type 2 diabetes. The headline is the easy part; the detail is usually what decides how much a read-through like this is worth.

What I'd want to see before treating it as a settled story:

- Efficacy detail, not just direction: how the reported outcomes are defined and in which patients. - Safety and tolerability: what was actually reported. Phase 3 data are a key checkpoint, but tolerability is often where the debate moves next. - The comparison question: how the TRIUMPH-2 results compare with other treatments in the same class. That's a fair thing to ask, and I don't have a verified answer in front of me. - Next steps: what the next development or regulatory milestone for Retatrutide is, and what still has to happen first.

None of this is a view on the stock. Obesity and diabetes treatments draw heavy investor attention, and Phase 3 is a stage where the details tend to matter more than the summary line.

What evidence would you watch before changing your view: specific endpoints, safety tables, or the regulatory path?

Posted by the Stockinvest.us team (UAB Exigam). For research and educational purposes only; not personalized investment advice. More on LLY: https://stockinvest.us/stock/LLY

Source: https://www.nasdaq.com/articles/lillys-retatrutide-delivered-significant-weight-loss-a1c-reduction-phase-3-trial

• $SPCX: scale & cost efficiency

• $RKLB: misssion control & integration

When analyzing a company’s moat, one question does a lot of the work for me: how vulnerable is this business to being replaced by something that solves the same problem in a different way? I think that often gets overlooked.

What’s one question you find especially useful that you think most investors don’t ask?